Citigroup’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Sell |
|
|||||
|
2025
Q1 | $266K | Sell |
|
|||||
|
2024
Q4 | $305K | Buy |
|
|||||
|
2024
Q3 | $234K | Buy |
|
|||||
|
2024
Q2 | $126K | Sell |
|
|||||
|
2024
Q1 | $230K | Buy |
|
|||||
|
2023
Q4 | $166K | Buy |
|
|||||
|
2023
Q3 | $48.1K | Sell |
|
|||||
|
2023
Q2 | $255K | Buy |
|
|||||
|
2023
Q1 | $76.5K | Sell |
|
|||||
|
2022
Q4 | $90K | Sell |
|
|||||
|
2022
Q3 | $118K | Sell |
|
|||||
|
2022
Q2 | $162K | Sell |
|
|||||
|
2022
Q1 | $197K | Buy |
|
|||||
|
2021
Q4 | $226K | Sell |
|
|||||
|
2021
Q3 | $271K | Buy |
|
|||||
|
2021
Q2 | $144K | Buy |
|
|||||
|
2021
Q1 | $128K | Sell |
|
|||||
|
2020
Q4 | $371K | Buy |
|
|||||
|
2020
Q3 | $143K | Sell |
|
|||||
|
2020
Q2 | $819K | Buy |
|
|||||
|
2020
Q1 | $432K | Buy |
|
|||||
|
2019
Q4 | $356K | Buy |
|
|||||
|
2019
Q3 | $138K | Sell |
|
|||||
|
2019
Q2 | $231K | Buy |
|
|||||
|
2019
Q1 | $285K | Buy |
|
|||||
|
2018
Q4 | $166K | Buy |
|
|||||
|
2018
Q3 | $59K | Buy |
|
|||||
|
2018
Q2 | $9K | Buy |
|
|||||
|
2018
Q1 | $5K | Sell |
|
|||||
|
2017
Q4 | $10K | Sell |
|
|||||
|
2017
Q3 | $332K | Buy |
|
|||||
|
2017
Q2 | $8K | Sell |
|
|||||
|
2017
Q1 | $2.41M | Buy |
|
|||||
|
2016
Q4 | $593K | Buy |
|
|||||
|
2016
Q3 | $213K | Sell |
|
|||||
|
2016
Q2 | $156K | Sell |
|
|||||
|
2016
Q1 | $384K | Buy |
|
|||||
|
2015
Q4 | $178K | Buy |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $70K | Sell |
|
|||||
|
2015
Q1 | $120K | Sell |
|
|||||
|
2014
Q4 | $206K | Buy |
|
|||||
|
2014
Q3 | $42K | Buy |
|
|||||
|
2014
Q2 | $50K | Buy |
|